Senior insider sale
BRIDGEBIO PHARMA, INC. — senior position signals high conviction
$1.87M
23.70K shares
What this filing means
SCOTT RANDAL W. plans to sell 23.70K shares of BRIDGEBIO PHARMA, INC. valued at approximately $1.87M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/17/2026ACC: 0001950047-26-008246
23.70K
Shares to sell
$1.87M
Approx. market value
21.50K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
8/17/2026
21.50KTotal acquired21.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/17/2026 | Exercise of Stock Options Cash | 21.50K | — |
| Total | 21.50K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.20K
Market value
$152.1K
6/24/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
21.50K
Market value
$1.72M
8/17/2026
Total
Units
23.70K
Value
$1.87M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/24/2026 | 2.20K | $152.1K | — | Completed |
| Planned — Approximate Date | ||||
8/17/2026 | 21.50K | $1.72M | NASDAQ | Planned |
| Total | 23.70K | $1.87M | ||